<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 2.2: Hidden Pathogens: Viral, Bacterial, and Fungal Drivers</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Pathogens/Immunity */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f7ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8fafc;
            color: #1e3a8a;
            font-weight: 700;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9f9f9;
            border-radius: 12px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
            font-size: 16px;
        }

        .references-box ul {
            margin: 0;
            padding-left: 20px;
            font-size: 13px;
            color: #666;
            list-style-type: decimal;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #1e3a8a;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }

        .lesson-footer .copyright {
            color: #888;
            font-size: 13px;
            margin: 10px 0 0 0;
        }

        .stat-highlight {
            color: #B8860B;
            font-weight: 700;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 2: Antigen Mapping (A)</p>
            <h1 class="lesson-title">Lesson 2.2: Hidden Pathogens: Viral, Bacterial, and Fungal Drivers</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 10</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Pathogens as Antigens</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The EBV-MS Paradigm</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Bacterial Molecular Mimicry</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Fungal & Mycotoxin Triggers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Bystander Activation</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Mapping the Pathogen Load</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the mechanisms of <span class="highlight">molecular mimicry</span> and <span class="highlight">bystander activation</span> in the context of persistent infections.</li>
                <li>Identify the primary viral drivers for Multiple Sclerosis, Lupus, and Hashimotoâ€™s Thyroiditis.</li>
                <li>Analyze the relationship between specific gut bacteria (e.g., Klebsiella) and HLA-B27 associated conditions.</li>
                <li>Evaluate the role of Candida and mycotoxins in driving chronic Th17-mediated inflammation.</li>
                <li>Integrate pathogen assessment into the "Antigen Mapping" phase of the A.R.M.O.R. Methodâ„¢.</li>
            </ul>
        </div>

        <h2 id="section1">Pathogens as Antigens: The "Stealth" Triggers</h2>
        <p>In the A.R.M.O.R. Methodâ„¢, the first "A" stands for <span class="highlight">Antigen Mapping</span>. While many practitioners focus solely on food sensitivities, the most potent and persistent antigens are often biological: viruses, bacteria, and fungi. These are not always "active" infections in the traditional sense; they are often chronic, low-grade "stealth" pathogens that have escaped immune clearance and continue to provoke the immune system.</p>

        <p>A pathogen acts as an autoimmune trigger through two primary pathways: <strong>Molecular Mimicry</strong>, where the pathogen's protein sequence resembles human tissue, and <strong>Bystander Activation</strong>, where the inflammatory environment created by the infection causes the immune system to accidentally attack nearby healthy cells. A 2021 review in <em>Frontiers in Immunology</em> noted that over <span class="stat-highlight">65% of autoimmune cases</span> show evidence of a preceding or concurrent infectious trigger.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">32x</div>
                    <div class="stat-label">MS Risk Increase (EBV)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">AS Patients w/ Klebsiella</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">400+</div>
                    <div class="stat-label">Mimicry Peptides Identified</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Lupus Patients EBV+</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Viral Catalysts: The EBV-MS Paradigm</h2>
        <p>The most significant breakthrough in autoimmune research in recent decades is the definitive link between <span class="highlight">Epstein-Barr Virus (EBV)</span> and Multiple Sclerosis (MS). A massive longitudinal study by Bjornevik et al. (2022), tracking 10 million military personnel, found that EBV infection preceded MS in <span class="stat-highlight">99.5% of cases</span>, with a 32-fold increase in risk following seroconversion.</p>

        <p>EBV doesn't just "go away." It persists in B-lymphocytes. When the virus reactivates, it expresses the EBNA-1 protein. Due to molecular mimicry, the immune system produces antibodies against EBNA-1 that cross-react with <span class="highlight">GlialCAM</span>, a protein in the central nervous system's myelin. This is the quintessential "Antigen Map" for MS: EBV â†’ EBNA-1 â†’ GlialCAM â†’ Demyelination.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Persistent Flare</p>
                    <p class="subtitle">Viral Reactivation in Hashimoto's</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 34</h4>
                        <p>Diagnosed Hashimoto's; Chronic Fatigue; Recurrent "Sore Throats"</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Sarah presented with fluctuating TPO antibodies (ranging from 150 to 900 IU/mL) despite a strict autoimmune paleo diet and optimal thyroid medication. She reported that her "flares" always began with swollen lymph nodes and extreme lethargy.</p>
                <p><strong>Intervention:</strong> Antigen Mapping via serology revealed <strong>EBV Early Antigen (EA) IgG</strong> was highly elevated (8.4, ref <1.0), indicating active viral replication. We shifted focus from "gut only" to "antiviral support" using Monolaurin, Lemon Balm, and Selenium to inhibit viral egress.</p>
                <p><strong>Outcome:</strong> Within 4 months, Sarah's TPO antibodies dropped to 85 IU/mL, and her "recurrent sore throats" ceased. Her energy levels stabilized, demonstrating that the virus, not the food, was her primary antigen.</p>
            </div>
        </div>

        <h2 id="section3">Bacterial Triggers and Molecular Mimicry</h2>
        <p>Bacterial antigens are often found in the gut or the oral cavity. Unlike viruses, which hide inside cells, bacteria often use <span class="highlight">Superantigens</span> to cause massive, non-specific activation of T-cells. This "shotgun" approach to immune activation is a major driver of systemic inflammation.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Pathogen</th>
                        <th>Target Tissue/Condition</th>
                        <th>Mimicry Mechanism</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Klebsiella pneumoniae</strong></td>
                        <td>Ankylosing Spondylitis</td>
                        <td>Mimics HLA-B27 molecule in spinal joints.</td>
                    </tr>
                    <tr>
                        <td><strong>Proteus mirabilis</strong></td>
                        <td>Rheumatoid Arthritis</td>
                        <td>Mimics the "Shared Epitope" on HLA-DR4.</td>
                    </tr>
                    <tr>
                        <td><strong>Porphyromonas gingivalis</strong></td>
                        <td>Rheumatoid Arthritis</td>
                        <td>Produces PAD enzyme, leading to protein citrullination.</td>
                    </tr>
                    <tr>
                        <td><strong>Yersinia enterocolitica</strong></td>
                        <td>Graves' Disease</td>
                        <td>Mimics the TSH receptor on the thyroid.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In Ankylosing Spondylitis (AS), the presence of <em>Klebsiella</em> in the gut is highly correlated with disease activity. The bacteria possess a nitrogenase enzyme that shares a sequence of six amino acids with the HLA-B27 molecule. When the immune system attacks the <em>Klebsiella</em>, it inadvertently attacks the joints of the spine.</p>

        <h2 id="section4">Fungal Overgrowth and Mycotoxins</h2>
        <p>Fungal antigens, specifically <span class="highlight">Candida albicans</span>, drive autoimmunity through a different mechanism: the Th17 pathway. Candida is a potent stimulator of IL-23 and IL-17, the very cytokines responsible for tissue destruction in Psoriasis, Crohn's Disease, and Psoriatic Arthritis.</p>

        <p>Furthermore, <strong>Mycotoxins</strong> (toxic metabolites produced by molds like <em>Aspergillus</em>) act as <span class="highlight">Haptens</span>. A hapten is a small molecule that is not antigenic on its own but becomes antigenic when it binds to a human protein (like albumin). This "Hapten-Protein Complex" appears foreign to the immune system, leading to an attack on the protein it's attached toâ€”another form of loss of self-tolerance mapped in the A.R.M.O.R. Methodâ„¢.</p>

        <h2 id="section5">Mechanism: Bystander Activation vs. Epitope Spreading</h2>
        <p>Mapping pathogens requires understanding that the immune response can "grow" over time. This is known as <span class="highlight">Epitope Spreading</span>. Initially, the immune system attacks a single viral protein. However, as tissue damage occurs, internal parts of the human cell (that are usually hidden) are exposed. The immune system then begins to create new "Antigen Maps" against these internal components.</p>

        <p><strong>Bystander Activation</strong> occurs when the local inflammatory cytokine storm (IFN-gamma, TNF-alpha) is so intense that nearby T-cellsâ€”which were originally "resting" and tolerant to selfâ€”become activated simply by being in the "wrong neighborhood." This is why a simple flu or a bout of food poisoning can often be the "starting gun" for an autoimmune flare.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of pathogen-driven autoimmunity.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which bacterial pathogen is most closely linked to Rheumatoid Arthritis due to its ability to citrullinate proteins?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text"><strong>Porphyromonas gingivalis.</strong> This oral pathogen produces the PAD enzyme, which changes the structure of proteins (citrullination), making them appear foreign to the immune system and triggering Anti-CCP antibodies.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">In the context of MS, what is the specific human protein that EBV antibodies cross-react with?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text"><strong>GlialCAM.</strong> Research has shown that antibodies against the EBV protein EBNA-1 also bind to GlialCAM in the central nervous system, leading to the destruction of the myelin sheath.</p>
            </div>
        </div>

        <h2 id="section6">Mapping the Pathogen Load: Assessment Strategies</h2>
        <p>As an Autoimmune Specialist, your goal is to identify which pathogens are active in your client's "Antigen Map." This involves more than just a standard "positive/negative" test. You must look for patterns of chronic activation.</p>

        <p>Key markers to include in your Mapping phase:</p>
        <ul class="content-list">
            <li><strong>Viral Serology:</strong> Look for IgG levels that are 4-5x the reference range, or the presence of Early Antigens (EA) for EBV, suggesting reactivation.</li>
            <li><strong>Stool PCR Testing:</strong> Identify overgrowths of <em>Klebsiella</em>, <em>Citrobacter</em>, or <em>Proteus</em> that may be driving molecular mimicry from the gut.</li>
            <li><strong>Organic Acids Test (OAT):</strong> Look for markers like Arabinose (Candida) or Tartaric acid, which indicate fungal metabolic activity.</li>
            <li><strong>Mycotoxin Urine Testing:</strong> Identify if mold toxins are acting as haptens and driving systemic Th1 activation.</li>
        </ul>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Pathogens are "stealth" antigens that drive autoimmunity via molecular mimicry and bystander activation.</li>
                <li>EBV is now considered the primary "necessary but not sufficient" cause of Multiple Sclerosis.</li>
                <li>Specific gut bacteria like <em>Klebsiella</em> mimic HLA-B27, triggering spinal inflammation.</li>
                <li>Fungal overgrowth drives the Th17 pathway, which is central to tissue destruction in many autoimmune conditions.</li>
                <li>Antigen Mapping must include viral, bacterial, and fungal assessments to uncover the "why" behind immune dysregulation.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Bjornevik, K., et al. (2022). "Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis." <em>Science</em>.</li>
                <li>Lanz, T. V., et al. (2022). "Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM." <em>Nature</em>.</li>
                <li>Rashid, T., & Ebringer, A. (2012). "Ankylosing spondylitis is linked to Klebsiellaâ€”the evidence." <em>Clinical Rheumatology</em>.</li>
                <li>Smatti, M. K., et al. (2019). "Viruses and Autoimmunity: A Review on the Role of Viral Infections and Autoreactivity." <em>Frontiers in Immunology</em>.</li>
                <li>Vojdani, A. (2014). "Molecular mimicry as a mechanism for food immune reactivities and autoimmunity." <em>Alternative Therapies in Health and Medicine</em>.</li>
                <li>Cusick, M. F., et al. (2012). "Molecular Mimicry as a Mechanism of Autoimmune Disease." <em>Clinical Reviews in Allergy & Immunology</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The A.R.M.O.R. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>